Drug Labeling

"Drug Labeling" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Use of written, printed, or graphic materials upon or accompanying a drug container or wrapper. It includes contents, indications, effects, dosages, routes, methods, frequency and duration of administration, warnings, hazards, contraindications, side effects, precautions, and other relevant information.

Descriptor ID	D004348
MeSH Number(s)	E05.916.310 J01.576.655.750.321.400 J01.576.761.300.400
Concept/Terms	Drug Labeling Drug Labeling Labeling, Drug Drug Labelling Labelling, Drug Package Inserts, Drug Drug Package Insert Drug Package Inserts Insert, Drug Package Inserts, Drug Package Package Insert, Drug Product Labeling, Drug Drug Product Labeling Labeling, Drug Product Black Box Warning Black Box Warning Black Box Warnings Box Warning, Black Box Warnings, Black Warning, Black Box Warnings, Black Box Boxed Warning Boxed Warnings Warning, Boxed Warnings, Boxed

Below are MeSH descriptors whose meaning is more general than "Drug Labeling".

Analytical, Diagnostic and Therapeutic Techniques and Equipment [E]
Investigative Techniques [E05]
Technology, Pharmaceutical [E05.916]
Drug Labeling [E05.916.310]
Technology, Industry, Agriculture [J]
Technology, Industry, and Agriculture [J01]
Industry [J01.576]
Manufacturing Industry [J01.576.655]
Drug Industry [J01.576.655.750]
Drug Packaging [J01.576.655.750.321]
Drug Labeling [J01.576.655.750.321.400]
Product Packaging [J01.576.761]
Drug Packaging [J01.576.761.300]
Drug Labeling [J01.576.761.300.400]

Below are MeSH descriptors whose meaning is related to "Drug Labeling".

Below are MeSH descriptors whose meaning is more specific than "Drug Labeling".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Drug Labeling" by people in this website by year, and whether "Drug Labeling" was a major or minor topic of these publications.

Bar chart showing 17 publications over 13 distinct years, with a maximum of 3 publications in 2015

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
2002	0	1	1
2003	0	1	1
2006	1	0	1
2007	1	1	2
2008	0	1	1
2011	0	1	1
2012	0	1	1
2014	0	1	1
2015	1	2	3
2017	1	1	2
2019	1	0	1
2020	0	1	1
2022	0	1	1

Below are the most recent publications written about "Drug Labeling" by people in Profiles.

Lusk C, Catchpole K, Neyens DM, Goel S, Graham R, Elrod N, Paintlia A, Alfred M, Joseph A, Jaruzel C, Tobin C, Heinke T, Abernathy JH. Improving safety in the operating room: Medication icon labels increase visibility and discrimination. Appl Ergon. 2022 Oct; 104:103831.

View in: PubMed
Hoque S, Chen BJ, Schoen MW, Carson KR, Keller J, Witherspoon BJ, Knopf KB, Yang YT, Schooley B, Nabhan C, Sartor O, Yarnold PR, Ray P, Bobolts L, Hrushesky WJ, Dickson M, Bennett CL. End of an era of administering erythropoiesis stimulating agents among Veterans Administration cancer patients with chemotherapy-induced anemia. PLoS One. 2020; 15(6):e0234541.

View in: PubMed
McDermott MS, Li G, McNeill A, Hammond D, Thrasher JF, O'Connor RJ, Cummings KM, Borland R, Fong GT, Hitchman SC. Exposure to and perceptions of health warning labels on nicotine vaping products: findings from the 2016 International Tobacco Control Four Country Smoking and Vaping Survey. Addiction. 2019 10; 114 Suppl 1:134-143.

View in: PubMed
Bian J, Norris LB, Bennett CL. Reply to A.M. Zeidan et al. J Clin Oncol. 2017 10 01; 35(28):3265.

View in: PubMed
Bian J, Chen B, Hershman DL, Marks N, Norris L, Schulz R, Bennett CL. Effects of the US Food and Drug Administration Boxed Warning of Erythropoietin-Stimulating Agents on Utilization and Adverse Outcome. J Clin Oncol. 2017 Jun 10; 35(17):1945-1951.

View in: PubMed
Basco WT, Garner SS, Ebeling M, Freeland KD, Hulsey TC, Simpson K. Evaluating the Potential Severity of Look-Alike, Sound-Alike Drug Substitution Errors in Children. Acad Pediatr. 2016 Mar; 16(2):183-91.

View in: PubMed
Hill KD, Henderson HT, Hornik CP, Li JS. Paediatric cardiovascular clinical trials: an analysis of ClinicalTrials.gov and the Food and Drug Administration Pediatric Drug Labeling Database. Cardiol Young. 2015 Aug; 25 Suppl 2:172-80.

View in: PubMed
Winterfield L, Vleugels RA, Park KK. The Value of the Black Box Warning in Dermatology. J Drugs Dermatol. 2015 Jul; 14(7):660-6.

View in: PubMed
Thrasher JF, Osman A, Moodie C, Hammond D, Bansal-Travers M, Cummings KM, Borland R, Yong HH, Hardin J. Promoting cessation resources through cigarette package warning labels: a longitudinal survey with adult smokers in Canada, Australia and Mexico. Tob Control. 2015 Mar; 24(e1):e23-31.

View in: PubMed
Chen B, Restaino J, Norris L, Xirasagar S, Qureshi ZP, McKoy JM, Lopez IS, Trenery A, Murday A, Kahn A, Mattison DR, Ray P, Sartor O, Bennett CL. A tale of two citizens: a State Attorney General and a hematologist facilitate translation of research into US Food and Drug Administration actions--a SONAR report. J Oncol Pract. 2012 Nov; 8(6):e158-67.

View in: PubMed

People

Explore

Similar Concepts

Top Journals